Archives for February 7, 2013

← 2013

GSK not A-OK with Ribena, Lucozade? Strategic review begins…

07-Feb-2013

By Ben BOUCKLEY

GlaxoSmithKline (GSK) has launched a strategic review of its Lucozade and Ribena brands, hinting that the western-facing brands do not fit its increased focus on emerging markets such as China and India.

Dangerous drug-laced ‘Brazilian slimming coffee’ brand still sold in US

07-Feb-2013

By Ben BOUCKLEY

Despite a Food and Drug Administration (FDA) warning that a sibutramine-laced ‘Brazilian Slimming Coffee’ may pose a 'significant risk' to some US consumers, the product is still widely available online.